These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23615477)

  • 1. Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform.
    Liu R; Peng Y; Li X; Wang Y; Pan E; Guo W; Pu Y; Yin L
    Int J Mol Sci; 2013 Apr; 14(5):8899-911. PubMed ID: 23615477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards Tyrosine Metabolism in Esophageal Squamous Cell Carcinoma.
    Cheng J; Zheng G; Jin H; Gao X
    Comb Chem High Throughput Screen; 2017; 20(2):133-139. PubMed ID: 28000565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.
    Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G
    Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma free amino acid profiling of esophageal cancer using high-performance liquid chromatography spectroscopy.
    Ma H; Hasim A; Mamtimin B; Kong B; Zhang HP; Sheyhidin I
    World J Gastroenterol; 2014 Jul; 20(26):8653-9. PubMed ID: 25024622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of choline kinase drives aberrant choline metabolism in esophageal squamous cell carcinomas.
    Ma W; Wang S; Zhang T; Zhang EY; Zhou L; Hu C; Yu JJ; Xu G
    J Pharm Biomed Anal; 2018 Jun; 155():148-156. PubMed ID: 29631075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers.
    Xu J; Chen Y; Zhang R; Song Y; Cao J; Bi N; Wang J; He J; Bai J; Dong L; Wang L; Zhan Q; Abliz Z
    Mol Cell Proteomics; 2013 May; 12(5):1306-18. PubMed ID: 23397110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging.
    Xu J; Chen Y; Zhang R; He J; Song Y; Wang J; Wang H; Wang L; Zhan Q; Abliz Z
    Sci Rep; 2016 Oct; 6():35010. PubMed ID: 27725730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of plasma metabolites associated with chemoradiosensitivity in esophageal squamous cell carcinoma via untargeted metabolomics approach.
    Zhang Y; Wang J; Dai N; Han P; Li J; Zhao J; Yuan W; Zhou J; Zhou F
    BMC Cancer; 2020 Sep; 20(1):835. PubMed ID: 32878621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum metabolomic signatures of lymph node metastasis of esophageal squamous cell carcinoma.
    Jin H; Qiao F; Chen L; Lu C; Xu L; Gao X
    J Proteome Res; 2014 Sep; 13(9):4091-103. PubMed ID: 25162382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC-MS-based serum metabolomic analysis reveals dysregulation of phosphatidylcholines in esophageal squamous cell carcinoma.
    Mir SA; Rajagopalan P; Jain AP; Khan AA; Datta KK; Mohan SV; Lateef SS; Sahasrabuddhe N; Somani BL; Keshava Prasad TS; Chatterjee A; Veerendra Kumar KV; VijayaKumar M; Kumar RV; Gundimeda S; Pandey A; Gowda H
    J Proteomics; 2015 Sep; 127(Pt A):96-102. PubMed ID: 25982385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid Identification of Biomarkers in Esophageal Squamous Cell Carcinoma by Lipidomic Analysis.
    Si T; Liu D; Li L; Xu Z; Jiang L; Zhai Y; Wu Q
    Nutr Cancer; 2024; 76(7):608-618. PubMed ID: 38753560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tubulin beta chain, filamin A alpha isoform 1, and cytochrome b-c1 complex subunit 1 as serological diagnostic biomarkers of esophageal squamous cell carcinoma: a proteomics study.
    Fan NJ; Gao CF; Wang XL
    OMICS; 2013 Apr; 17(4):215-23. PubMed ID: 23496306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method.
    Zhao J; Fan YX; Yang Y; Liu DL; Wu K; Wen FB; Zhang CY; Zhu DY; Zhao S
    Int J Clin Exp Pathol; 2015; 8(2):1535-44. PubMed ID: 25973038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining fecal microbiome and metabolomics reveals diagnostic biomarkers for esophageal squamous cell carcinoma.
    Gao M; Wu J; Zhou S; Chen Y; Wang M; He W; Jiang L; Shu Y; Wang X
    Microbiol Spectr; 2024 May; 12(5):e0401223. PubMed ID: 38497715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.
    Cui Y; Xue Y; Dong S; Zhang P
    J Int Med Res; 2017 Aug; 45(4):1310-1317. PubMed ID: 28587538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
    Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF
    Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-Omics Analysis Reveals the Role of Changes in Platelet Activation Pathways in the Survival Outcome of Patients with Esophageal Squamous Cell Carcinoma.
    Wang H; Li Z; Yao X; Cheng L; Liu Q; Hu Q; Zhou Q; Yang Q; He H; Cai S; Fang L; Li K; Wang Z; Wen H; Zhou C; Fu M; Cao C
    Altern Ther Health Med; 2024 Oct; 30(10):538-544. PubMed ID: 38401086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Liu LH; Shan BE; Tian ZQ; Sang MX; Ai J; Zhang ZF; Meng J; Zhu H; Wang SJ
    Clin Chem Lab Med; 2010 Jun; 48(6):855-61. PubMed ID: 20345231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of extracellular matrix protein 1 as a potential plasma biomarker of ESCC by proteomic analysis using iTRAQ and 2D-LC-MS/MS.
    Wang X; Peng Y; Xie M; Gao Z; Yin L; Pu Y; Liu R
    Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28493612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomic profiling reveals potential biomarkers in esophageal cancer progression using liquid chromatography-mass spectrometry platform.
    Zhang H; Wang L; Hou Z; Ma H; Mamtimin B; Hasim A; Sheyhidin I
    Biochem Biophys Res Commun; 2017 Sep; 491(1):119-125. PubMed ID: 28711496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.